David Meline | 68 Independent Director since: 2023 Current role: Director HP board committees: Audit (Chair), Finance, Investment and Technology Current public company boards HP ABB Ltd. Lonza Group Ltd Eikon Therapeutics, Inc. Prior public company boards Pacific Biosciences of California, Inc. Qualifications: Prior business and other experience CFO, Moderna Inc., a biotechnology and pharmaceutical company (June 2020 September 2022) CFO and Executive Vice President, Amgen Inc., a biotechnology company (July 2014 December 2019) CFO and Senior Vice President (2011 2014) and Vice President, Corporate Controller and Chief Accounting Officer (2008 2011), 3M Company In 20 years at General Motors, Mr. Meline served in a variety of finance and management roles Other key qualifications Mr. Meline brings to the Board deep background and breadth of experience in finance, capital allocation, manufacturing and technology. From his prior CFO roles at three global companies, Mr. Meline has experience driving operational performance, scaling growth businesses and delivering strong financial performance. Mr. Meline also provides the Board with substantial knowledge in the biotechnology and pharmaceutical sectors. Skills: Business and management Finance and capital allocation Operations Technology, cybersecurity and science Customer experience Government and government affairs Risk management Disruptive innovation Human capital management Strategic transactions; M&A Environmental and societal matters International business and affairs Strategy